Clinical Trials About "Global Chinese Epoprostenol 61849147 Industry 2017 Market Research" - Page: 20 RSS

20:13 EDT 19th September 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Global Chinese Epoprostenol 61849147 Industry 2017 Market Research" on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Global Chinese Epoprostenol 61849147 Industry 2017 Market Research" on BioPortfolio

We have published hundreds of Global Chinese Epoprostenol 61849147 Industry 2017 Market Research news stories on BioPortfolio along with dozens of Global Chinese Epoprostenol 61849147 Industry 2017 Market Research Clinical Trials and PubMed Articles about Global Chinese Epoprostenol 61849147 Industry 2017 Market Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Chinese Epoprostenol 61849147 Industry 2017 Market Research Companies in our database. You can also find out about relevant Global Chinese Epoprostenol 61849147 Industry 2017 Market Research Drugs and Medications on this site too.

Showing "Global Chinese Epoprostenol 61849147 Industry 2017 Market Research" Clinical Trials 476–500 of 13,000+

Probably Relevant

Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)

Functional dyspepsia (FD), which is one of the most common gastrointestinal disorders with high disease burden. Postprandial distress syndrome (PDS) is a common subtype of FD. Although the effectiveness of Chinese herbal formula of Xiang-sha-liu-jun granule (XSLJG) for alleviating PDS symptoms has been assessed in previous studies, more convinced evidence of randomized placebo-controlled study is needed.

The Efficacy and Safety of Chinese Herbal Medicine YH1 as Add-On Medication in Poorly Controlled Type 2 Diabetes Patients: A Randomized Double-Blind Placebo-Controlled Trial

Type 2 diabetes mellitus is a chronic metabolic disease that seriously affects patients worldwide, and it is always among the top 10 causes of death in Taiwan. To date, still many patients who take more than three kinds of oral hypoglycemic agents could not effectively control their HbA1c levels in clinics. Hypoglycemia as well as weight gain are common side effect with insulin therapy, and many patients in Taiwan are not willing to receive insulin injection. It is common for d...

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)

This is a single center, randomized, double-blind, dose-escalation, placebo-controlled phase 1 clinical trial. This study will determine the safety and side-effect profile of an investigational dexlansoprazole injection after single intravenous administration in healthy Chinese adults.

Japanese Post-Market Cohort Study

The Tobacco Heating System (THS 2.2) which is commercialized under the iQOS brand name (as described in the study protocol) in Japan is subject to an assessment program which includes post-market studies such as the Japanese Post-Market Cohort Study. The objectives and endpoints of this Post-Market Cohort Study will be analyzed in the study population of adult tobacco users and never smokers in Japan. This includes: - Provide a perspective of tobacco product use in a "real...

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers

This single-center, open-label study will evaluate the pharmacokinetics, safety, and tolerability of emicizumab following a single subcutaneous (SC) administration to healthy Chinese subjects.

Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases

To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic rheumatic disease

Breast Health in Chinese American Women

This four-and-a-half-year study will test the efficacy of viewing a theoretically based and culturally sensitive video followed by group discussion (vs. single viewing) in increasing mammography use. The results of this study will lead cancer control efforts to effectively decrease breast cancer screening disparities experienced by Chinese-America women.

A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)

This was an open, randomized, comparative study using rhCG (Ovidrel) in the induction of final follicle maturation and early luteinization in Chinese female subjects undergoing IVF or ET.

Breastfeed a Better Youngster: the BABY Study

This research will investigate different aspects of the 'signalling' between mother and infant during breastfeeding in a stressful situation following late preterm delivery, when breastfeeding is often challenging. The researcher will conduct a single-blinded randomised controlled trial in Chinese mothers who deliver a late preterm infant (LPI; 34-

Sidus(TM) Post Market Clinical Follow-up (PMCF) Study

This post market clinical follow-up study is designed to confirm safety and performance of the Sidus Stem-Free Shoulder when used in hemi or total shoulder arthroplasty. The safety of the implant will be evaluated by monitoring the frequency and incidence of all kinds of adverse events. The performance will be determined by analyzing the implant survival, overall pain and functional performances (based on Constant & Murley score and ASES score), subject quality of life ...

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese

Overweight/obese Chinese and prediabetes will be recruited and divided into three age-matched groups including high intensity exercise, moderate intensity exercise, and non-exercise groups. The exercise program will consist of three sessions per week over the course of 12 weeks, under the supervision of our in-house exercise specialists and physiologists. The effects of exercise on glucose and lipid profiles, insulin sensitivity and adiposity will be evaluated.

A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

This study will characterize the pharmacokinetics (PK) of AK0529, the effect of food and evaluate the safety of AK0529 in healthy Chinese adult subjects. 50 subjects will be randomized to receive a dose level of AK0529 or placebo in five groups. The total study duration will be approximately 18-27 days for each subject.

Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) and Olodaterol 5μg in Chinese COPD Patients

The primary objective of this study is to assess the pharmacokinetics of olodaterol monotherapy (5 μg) and tiotropium + olodaterol Fixed Dose Combination (FDC) ( 5 μg/ 5 μg) delivered by the RESPIMAT inhaler after single dose and at steady state in Chinese patients with Chronic Obstructive Pulmonary Disease (COPD). The secondary objective is to assess the safety of olodaterol monotherapy (5 μg) and tiotropium +olodaterol FDC (5 μg/ 5 μg) delivered by the RESPIMAT inhaler...

Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers

The purpose of this study is to determine the safety of the study drug known as abemaciclib in native Chinese participants with advanced and/or metastatic cancers.

CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

This randomized, double blind, phase 2/3 study is aimed to evaluate the efficacy and safety of CM082 in combination with everolimus in Chinese patients with advanced renal cell carcinoma. The primary endpoint is progression-free survival.

OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients

This is an open-label, randomized, single-dose, parallel group study. The objectives of this study are to assess pharmacokinetics of oxycodone and naloxone from oxycodone/naloxone (OXN) prolonged release (PR) tablet 5/2.5 mg (OXN 5/2.5) and 20/10 mg (OXN 20/10) in Chinese patients with moderate to severe chronic non-malignant pain.

A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to evaluate pharmacokinetics (PK) following a single dose and multiple dose treatment and the safety of apalutamide in Chinese participants with metastatic castration resistant prostate cancer (mCRPC) at dose of 240 milligram (mg).

A Study of BNC210 in Elderly Patients With Agitation

This is a Phase II randomised, double-blind, placebo-controlled study assessing the effects of BNC210 on agitation in hospitalised elderly patients as measured by the Pittsburgh Agitation Scale (PAS). The secondary objectives of the study are to evaluate the effects of BNC210 on global function in patients with agitation as assessed by the Clinical Global Impression Scale (CGI-S/I). Safety and tolerability of BNC210 will also be assessed. Participants will receive 5 day...

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

The purpose of this study is to assess the pharmacokinetics after a single dose of dexlansoprazole 30 and 60 mg delayed-release capsules in healthy Chinese participants.

AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.

Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor

Study E7080-C086-108 is an open-label, single- and multiple-dose pharmacokinetic (PK) study of lenvatinib (administered orally, once a day [QD]) in Chinese participants with solid tumor. A total of 12 participants will be enrolled to evaluate the PK of 24 milligrams (mg) QD dosing of lenvatinib.

Expert System and Family Assisted Interventions for Chinese Smokers

In this study, we choose to specifically recruit Chinese, the largest ethnic group of the Asian and Pacific Islander community,2 as an initial step to increase our understanding of the role of family or supportive others in the process of smoking cessation among Asian Americans. We propose the following specific aims for the study: 1. Examine the effectiveness of proactive recruitment of Chinese smokers into a smoking cessation treatment program through their family or...

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms

To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.

More From BioPortfolio on "Global Chinese Epoprostenol 61849147 Industry 2017 Market Research"

Quick Search